Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of TransCode Therapeutics, Inc. (NASDAQ:RNAZ) fell sharply during Friday’s session.

TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share.

TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

Here are some other stocks moving in today's mid-day session.

Gainers

• Charge Enterprises, Inc. (NASDAQ:CRGE) shares surged 105.4% to $0.2510.
• Kaman Corporation (NASDAQ:KAMN) shares climbed 101.3% to $45.14 after the company announced it will be acquired by Arcline for $1.8 billion.
• Mesa Air Group Inc (NASDAQ:MESA) gained 70.4% to $1.09 as the company entered into new agreements with United Airlines for improved operating and financing terms.
• Edgewise Therapeutics, Inc. (NASDAQ:EWTX) rose 37.3% to $13.30 after the company announced pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share.
• Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) climbed 34.2% to $0.2725. Processa Pharmaceuticals announced plans to expand the development of next generation capecitabine (NGC-Cap) into advanced or metastatic breast cancer beginning with next Phase 2 trial in breast cancer.
• Tricon Residential Inc. (NYSE:TCN) shares gained 28.2% to $11.06 Blackstone and Tricon Residential entered into an arrangement agreement under which Blackstone Real Estate Partners X together with Blackstone Real Estate Income Trust, Inc. will acquire all outstanding common shares of Tricon for $11.25 per share in cash.
• Spirit Airlines, Inc. (NYSE:SAVE) jumped 24% to $7.06 after the company announced preliminary fourth-quarter and full year 2023 estimates, issued first-quarter 2024 guidance and said the merger agreement between the company and JetBlue "remains in full force and effect."
• Super Micro Computer, Inc. (NASDAQ:SMCI) climbed 23.1% to $383.31 after the company announced updated financial guidance for the second-quarter, which surpassed its previous outlook.
• Allied Gaming & Entertainment Inc. (NASDAQ:AGAE) rose 20.6% to $1.1190.
• Portage Biotech Inc. (NASDAQ:PRTG) gained 19% to $1.14.
• ProMIS Neurosciences, Inc. (NASDAQ:PMN) gained 19% to $2.07.
• Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) gained 16.4% to $0.5185.
• Treasure Global Inc. (NASDAQ:TGL) shares rose 14.2% to $0.1176. Treasure Global and AIO Synergy recently entered into a strategic alliance aimed at reshaping the landscape of artificial intelligence.
• Silk Road Medical, Inc (NASDAQ:SILK) jumped 13.1% to $14.91 after Stifel upgraded the stock from Hold to Buy and raised its price target from $9 to $20.
• Wayfair Inc. (NYSE:W) jumped 11.6% to $56.81 after the company announced a workforce realignment plan, which includes a workforce reduction involving approximately 13% of its global workforce.
• Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) gained 10.6% to $4.30.
• NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) rose 10.5% to $19.44.
• World Acceptance Corporation (NASDAQ:WRLD) gained 10.2% to $134.00 following upbeat quarterly results.
• Ally Financial Inc. (NYSE:ALLY) gained 9.4% to $35.15. Synchrony Financial announced plans to acquire Ally Financial's point of sale financing business. Ally Financial also posted upbeat quarterly sales.
• Cyngn Inc. (NASDAQ:CYN) surged 8.8% to $0.1468 after gaining over 5% on Thursday.
• Mesoblast Limited (NASDAQ:MESO) gained 8.1% to $1.86 after the FDA granted a Rare Pediatric Disease Designation to the company’s Revascor® for treating children with congenital heart disease.
• WNS (Holdings) Limited (NYSE:WNS) rose 4.4% to $65.71. Needham analyst Mayank Tandon maintained WNS with a Buy and raised the price target from $80 to $85.

Losers

• C3is Inc. (NASDAQ:CISS) shares fell 63.2% to $0.1384 as the company announced pricing of $7.0 million upsized underwritten public offering.
• Azitra, Inc. (NYSE:AZTR) dipped 31.8% to $1.3976 after the company filed for a firm commitment public offering of 3 million shares of common stock.
• iRobot Corporation (NASDAQ:IRBT) fell 30% to $16.53 following a report suggesting the EU plans to block Amazon's acquisition of the company.
• Accelerate Diagnostics, Inc. (NASDAQ:AXDX) fell 27.1% to $1.17 after the company reported pricing of approximately $15 million public offering and private placement.
• AST SpaceMobile, Inc. (NASDAQ:ASTS) declined 24.3% to $3.15. AST SpaceMobile announced a $100 million offering of common stock. The company also announced a strategic investment from AT&T Inc (NYSE:T),
• Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) and Vodafone.
• Agrify Corporation (NASDAQ:AGFY) dipped 21.9% to $1.0699. Agrify entered into a multi-million dollar sales agreement with Ocean Deep/Golden Lake Business Park.
• Adagene Inc. (NASDAQ:ADAG) fell 21.6% to $2.64.
• BioCardia, Inc. (NASDAQ:BCDA) fell 20% to $0.46.
• Volato Group, Inc. (NYSE:SOAR) fell 17.2% to $2.1688.
• Datasea Inc. (NASDAQ:DTSS) shares fell 16.4% to $0.1140. Datasea announced plans for a 1-for-15 reverse stock split to regain compliance with Nasdaq minimum bid requirement.
• Orgenesis Inc. (NASDAQ:ORGS) dipped 15.3% to $0.2711.
• Wheels Up Experience Inc. (NYSE:UP) fell 12.6% to $3.19.
• Nkarta, Inc. (NASDAQ:NKTX) fell 12.2% to $7.47.
• Vision Marine Technologies Inc. (NASDAQ:VMAR) shares fell 11.5% to $0.7098. Vision Marine Technologies announced close of $3.0 million private placement of convertible preferred shares and warrants with Investissement Québec.
• Absci Corporation (NASDAQ:ABSI) dipped 11.3% to $3.2120.
• Lithium Americas Corp. (NYSE:LAC) fell 10.4% to $4.3650.
• Celsius Holdings, Inc. (NASDAQ:CELH) fell 10% to $53.60 after B of A Securities downgraded the stock from Buy to Neutral and announced a $65 price target.
• Hut 8 Corp. (NYSE:HUT) dipped 9.4% to $6.45.
• Lifezone Metals Limited (NYSE:LZM) fell 9.3% to $6.37.
• MorphoSys AG (NASDAQ:MOR) fell 7.3% to $9.49 after falling 6% on Wednesday. Morgan Stanley analyst James Quigley, on Tuesday, downgraded MorphoSys from Overweight to Equal-Weight.
• Hertz Global Holdings, Inc. (NASDAQ:HTZ) declined 6.6% to $8.40 after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $12 to $8.
• Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares fell 6.1% to $2.0188. Esperion priced its $85.1 million public offering of 56.7 million common share at $1.50 per share.
• Chegg, Inc. (NYSE:CHGG) shares fell 6.1% to $9.45. Goldman Sachs analyst Eric Sheridan downgraded Chegg from Neutral to Sell and lowered the price target from $10 to $8.

Now Read This: Jim Cramer Predicts A 'Terrific Year' For This Manufacturer, And As For U-Haul? 'I'm Fine With It'